Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

111 results
Display

Depigmentation in a Patient with Chronic Myeloid Leukemia during Chemotherapy with Dasatinib

Choi YW, Na N, Park J

  • KMID: 2451599
  • Korean J Dermatol.
  • 2019 Jun;57(5):292-293.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
First case report of latent tuberculosis reactivation complicating treatment with nilotinib in chronic myeloid leukemia

Kim DJ, Jeong S, Kong SG, Lee HS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Isolated monocytosis was the flag preceding abnormalities in other parameters of complete blood counts in chronic myeloid leukemia with e1a2 (minor, P190) BCR-ABL1 chimeric transcripts

Yun JW, Yoon J, Kim JW, Kim SH, Jung CW, Kim HJ

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with the molecular hallmark of BCR-ABL1 chimeric transcripts from t(9;22)(q24;q22). In more than 95% of CML, the fusion occurs in the major...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib

Yi JH, Kim HR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy

Bedewy AM, Elmaghraby SM, Kandil NS

BACKGROUND: ATP-binding cassette transporters are important in the mechanism of multidrug resistance. ABCB1 displays a high affinity for imatinib. BMI1 is a polycomb group protein thought to be overexpressed in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
First Case of Transformation of Immunoglobulin Heavy Chain Variable-Mutated Chronic Lymphocytic Leukemia Into Chronic Myeloid Leukemia

Zhang X, Guo X

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Emergence of chronic myeloid leukemia following autologous stem cell transplantation in a young woman with multiple myeloma

Barrett A, Glavey S, Sargent J, Thornton P, Murphy P, Quinn J

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multifocal large aggregates of pseudo-Gaucher cells in chronic myeloid leukemia

Sharma P, Kumar N, Varma N

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dasatinib (Sprycel®)-Associated Acneiform Eruption Improved by Dose Reduction due to Pleural Effusion in a Patient with Chronic Myeloid Leukemia

Lim JH, Woo Y, Kim M, Park HJ

  • KMID: 2436860
  • Korean J Dermatol.
  • 2018 Aug;56(7):472-474.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia

Rajpal S, Nampoothiri RV, Sreedharanunni S, Parihar M, Malhotra P, Varma N

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia

Kavanagh S, Bril V, Lipton JH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The first concurrent diagnosis of acute symptomatic Babesiosis and chronic myeloid leukemia in a healthy young adult

Xie Y, Visconte V, Duan L, Rogers HJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML)

Švabek ZT, Josipović M, Horvat I, Zadro R, Davidović-Mrsić S

BACKGROUND: To analyze the frequency of atypical fluorescence in situ hybridization signal patterns and estimate the complete cytogenetic response (CCyR) and major molecular response (MMR) during 12 months of tyrosine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Additional cytogenetic aberrations in chronic myeloid leukemia: a single-center experience in the Middle East

Safaei A, Monabati A, Safavi M, Atashabparvar A, Hosseini M

BACKGROUND: Additional cytogenetic aberrations are associated with disease progression in chronic myeloid leukemia (CML). This study was conducted to determine the type and frequency of these aberrations and their relationship...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia

Yim E, Choi YG, Nam YJ, Lee J, Kim JA

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia

Jin C, Zhu X, Xiao M, Liu S, Liu X, Liu J, Xu X, Yi S, Meng L

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of synchronous multiple myeloma and chronic myeloid leukemia

Lee JY, Lee SM, Yoon HK, Kim KH, Choi MY, Lee WS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21

Zhou X, Yuan P, Liu Q, Liu Z

Imatinib resistance has become a major clinical problem for chronic myeloid leukemia. The aim of the present study was to investigate the involvement of MEG3, a lncRNA, in imatinib resistance...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hidden “Preleukemic Phase” of Chronic Myeloid Leukemia Presenting Without Leukocytosis in the Peripheral Blood Unrelated to Chemotherapy in a Patient Diagnosed With Diffuse Large B Cell Lymphoma

Yoo DW, Park SH, Yi J, Kim IS, Kim HH, Chang CL, Lee EY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute megakaryoblastic blast crisis as a presentation manifestation of chronic myelogenous leukemia

Bhattacharya JB, Gupta R, Samadhiya

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr